M Warm

400 total citations
23 papers, 239 citations indexed

About

M Warm is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, M Warm has authored 23 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in M Warm's work include Breast Cancer Treatment Studies (9 papers), Cancer Treatment and Pharmacology (7 papers) and Advanced Breast Cancer Therapies (5 papers). M Warm is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Cancer Treatment and Pharmacology (7 papers) and Advanced Breast Cancer Therapies (5 papers). M Warm collaborates with scholars based in Germany, Austria and Switzerland. M Warm's co-authors include Sherko Kümmel, Kay Friedrichs, Thorsten Kühn, Jens‐Uwe Blohmer, W. Eiermann, J. Hilfrich, Mahdi Rezai, Andreas Schneeweiß, Holger Eidtmann and Susanne Markmann and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

M Warm

22 papers receiving 232 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Warm Germany	7	123	106	48	47	43	23	239
C Jackisch Germany	10	142 1.2×	219 2.1×	88 1.8×	104 2.2×	31 0.7×	35	360
Erik Asmus United States	6	36 0.3×	100 0.9×	17 0.4×	43 0.9×	41 1.0×	9	179
M Tomšová Czechia	7	47 0.4×	251 2.4×	46 1.0×	56 1.2×	61 1.4×	22	387
Rita Ceccherini Italy	8	166 1.3×	182 1.7×	21 0.4×	16 0.3×	44 1.0×	15	272
И. А. Покатаев Russia	7	61 0.5×	141 1.3×	78 1.6×	23 0.5×	101 2.3×	86	246
Sushmita Gordhandas United States	9	74 0.6×	95 0.9×	30 0.6×	125 2.7×	24 0.6×	35	344
Alain Zannetti France	8	55 0.4×	83 0.8×	25 0.5×	39 0.8×	135 3.1×	15	228
Maria M. Rubinstein United States	10	50 0.4×	105 1.0×	34 0.7×	107 2.3×	44 1.0×	26	304
Shigeki Tanishima Japan	10	90 0.7×	87 0.8×	38 0.8×	29 0.6×	65 1.5×	20	208
Jennifer McLachlan United Kingdom	10	24 0.2×	113 1.1×	58 1.2×	116 2.5×	45 1.0×	21	280

Countries citing papers authored by M Warm

Since Specialization

Citations

This map shows the geographic impact of M Warm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Warm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Warm more than expected).

Fields of papers citing papers by M Warm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Warm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Warm. The network helps show where M Warm may publish in the future.

Co-authorship network of co-authors of M Warm

This figure shows the co-authorship network connecting the top 25 collaborators of M Warm. A scholar is included among the top collaborators of M Warm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Warm. M Warm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eichler, Christian, Fabinshy Thangarajah, Julia Caroline Radosa, et al.. (2022). Platelet-rich plasma (PRP) in oncological patients: long-term oncological outcome analysis of the treatment of subcutaneous venous access device scars in 89 breast cancer patients. Archives of Gynecology and Obstetrics. 306(4). 1171–1176. 6 indexed citations

Eichler, Christian, et al.. (2020). Platelet‐Rich Plasma (PRP) in Breast Cancer Patients: An Application Analysis of 163 Sentinel Lymph Node Biopsies. BioMed Research International. 2020(1). 3432987–3432987. 8 indexed citations

Kolberg‐Liedtke, Cornelia, Rachel Wuerstlein, Oleg Gluz, et al.. (2020). Phenotype Discordance between Primary Tumor and Metastasis Impacts Metastasis Site and Outcome: Results of WSG-DETECT-PriMet. Breast Care. 16(5). 475–483. 6 indexed citations

Thangarajah, Fabinshy, Christian Eichler, Wolfram Malter, et al.. (2019). The impact of EndoPredict ® on decision making with increasing oncological work experience: can overtreatment be avoided?. Archives of Gynecology and Obstetrics. 299(5). 1437–1442. 4 indexed citations

Goyal, Amit, Iris Scheffen, M Warm, et al.. (2018). Can internal surgical adhesive facilitate drain-free mastectomy? A randomized, prospective multicenter non-inferiority clinical study comparing wound closure with drains to wound closure with TissuGlu® and no drains in mastectomy. European Journal of Surgical Oncology. 44(6). 915–915.

Schmidt, Christian, M Warm, & F. Wolff. (2014). Management. Generation Y: Was erwartet uns von unseren Mitarbeiterinnen und Mitarbeitern?. Geburtshilfe und Frauenheilkunde. 74(1). 23–27. 1 indexed citations

Nitz, Ulrike, Oleg Gluz, I. Zuna, et al.. (2013). Final results from the prospective phase III WSG-ARA trial: impact of adjuvant darbepoetin alfa on event-free survival in early breast cancer. Annals of Oncology. 25(1). 75–80. 15 indexed citations

Eiermann, W., Mahdi Rezai, Sherko Kümmel, et al.. (2012). The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use. Annals of Oncology. 24(3). 618–624. 116 indexed citations

Fasching, PA, Maik Hauschild, Sherko Kümmel, et al.. (2012). Abstract PD07-02: Anticancer activity of letrozole plus zoledronic acid as neoadjuvant therapy for postmenopausal patients with breast cancer: FEMZONE trial results. Cancer Research. 72(24_Supplement). PD07–2. 2 indexed citations

10.

Eiermann, W., Sherko Kümmel, Thorsten Kühn, et al.. (2012). 302 Using the 21-gene Breast Cancer Assay in Adjuvant Decision-making in ER-positive (ER+) Early Breast Cancer (EBC) is Cost-effective: Results of a Large Prospective German Multicenter Study. European Journal of Cancer. 48. S130–S130. 2 indexed citations

11.

Paepke, Stefan, et al.. (2011). Zoledronat in der adjuvanten Therapie des rezeptornegativen Mammakarzinoms - Rationale und Erfahrungen mit Einzelfallentscheidungen. Geburtshilfe und Frauenheilkunde. 71(2). 135–139. 1 indexed citations

12.

Jäger, Eliézer, S-E. Al-Batran, Michael Schmidt, et al.. (2010). A randomized phase III study evaluating pegylated liposomal doxorubicin (PLD) versus capecitabine (CAP) as first-line therapy for metastatic breast cancer (MBC): Results of the PELICAN study.. Journal of Clinical Oncology. 28(15_suppl). 1022–1022. 9 indexed citations

13.

Wit, Meike de, Friedemann Honecker, Ulrich Wedding, et al.. (2010). Abstract P6-11-06: Correlation Comprehensive Geriatric Assessment (CGA) and Inflammation and Nutrition Parameters with Outcome Measures in the Phase III PELICAN Trial for Metastatic Breast Cancer (MBC). Cancer Research. 70(24_Supplement). P6–11. 1 indexed citations

14.

Warm, M, et al.. (2010). Critical analysis of care and payment within a DRG reimbursement system for primary breast cancer.. Journal of Clinical Oncology. 28(15_suppl). e16513–e16513. 1 indexed citations

15.

Nitz, Ulrike, C. Oberhoff, Toralf Reimer, et al.. (2009). Adjuvant chemotherapy with or without darbepoetin in node-positive breast cancer: a safety analysis from the phase III ARA plus trial.. Cancer Research. 69(2_Supplement). 4100–4100. 4 indexed citations

16.

Paepke, Stefan, E Klein, M Warm, et al.. (2009). Interim analysis of the multicenter phase II HEDON trial evaluating pathological response to pre-operative docetaxel and docetaxel+trastuzumab (T) in locally advanced breast cancer (BR) stratified by HER2-status. Journal of Clinical Oncology. 27(15_suppl). e11512–e11512. 1 indexed citations

17.

Graeser, Monika, Rachel Wuerstlein, R Schmutzler, et al.. (2008). Benchmarking als Qualitätssicherungsmassnahme in der Senologie und die Entwicklung von 2003 bis 2006 in Deutschland/NRW. Geburtshilfe und Frauenheilkunde. 68(3). 1 indexed citations

18.

Pujade-Lauraine, Éric, Andreas du Bois, A Goupil, et al.. (2005). Epirubicin/paclitaxel/carboplatin (TEC) vs paclitaxel/carboplatin (TC) in first-line treatment of ovarian cancer FIGO stages IIB-IV. Results of a randomized AGO-GINECO GCIG Intergroup phase III trial. International Journal of Gynecological Cancer. 15(s3). 222–223. 3 indexed citations

19.

Hoopmann, Markus, et al.. (2003). Recurrence of Breast Cancer in the Donor Site after Latissimus Dorsi Flap. Plastic & Reconstructive Surgery. 112(3). 819–821. 5 indexed citations

20.

Bois, Andreas du, Werner Meier, Volker Möbus, et al.. (1997). Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.. PubMed. 24(5 Suppl 15). S15–44. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact